TapewireFind a company

person · Reporting owner

ROBERTSON REBECCA B

Disclosed activity across 2 companies

Tapewire entity
41380
SEC CIK
0001201585

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Ceribell, Inc.CBLL · Entity 4994DirectorJune 02, 2026June 04, 2026
TANDEM DIABETES CARE INCTNDM · Entity 4682DirectorMay 20, 2026May 22, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Ceribell, Inc.

Report date June 02, 2026 · Filed June 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect26,587 Reported balance After 2026-06-02 transaction · row 1
1 source row

Row 1 · 2026-06-02 · Grant · Acquired 7,838 · Balance 26,587

F1: Represents restricted stock units ("RSUs").

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units ("RSUs").

TANDEM DIABETES CARE INC

Report date May 20, 2026 · Filed May 22, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect22,542 Reported balance After 2026-05-21 transaction · row 1
1 source row

Row 1 · 2026-05-21 · Exercise / conversion · Acquired 8,759 · Balance 22,542

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect10,220 Reported balance After 2026-05-20 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-20 · Grant · Acquired 10,220 · Balance 10,220

F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-05-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-05-21 · Exercise / conversion · Disposed 8,759 · Balance 0

F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.

F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 02, 2026 Filed Jun 4, 2026 21:05 UTC Ceribell, Inc. CBLL · Entity 4994 GrantCommon Stock 7,838 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-257714 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,587

F1 · shares: Represents restricted stock units ("RSUs").

Read SEC document
May 21, 2026 Filed May 22, 2026 20:06 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 8,759 $0.00 $0.00
Disclosure

SEC source: 0001438133-26-000074 · wk-form4_1779480402.xml · derivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,759 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F3 · derivative.exercise_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.

F3 · derivative.expiration_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:06 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 8,759 $0.00 $0.00
Disclosure

SEC source: 0001438133-26-000074 · wk-form4_1779480402.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,542

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2026 Filed May 22, 2026 20:06 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 10,220 $0.00 $0.00
Disclosure

SEC source: 0001438133-26-000074 · wk-form4_1779480402.xml · derivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,220

Underlying: Common Stock · 10,220 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F2 · derivative.exercise_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.

F2 · derivative.expiration_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 19:20 UTC Ceribell, Inc. CBLL · Entity 4994 SaleCommon Stock 827 $17.80 $14,720.60
Disclosure

SEC source: 0001193125-26-093506 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,749

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:16 UTC Ceribell, Inc. CBLL · Entity 4994 Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001193125-26-004760 · ownership.xml · derivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,650

Underlying: Common Stock · 2,500 shares

Expires 2029-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:16 UTC Ceribell, Inc. CBLL · Entity 4994 SaleCommon Stock 2,500 $21.89 $54,725.00
Disclosure

SEC source: 0001193125-26-004760 · ownership.xml · nonDerivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,576

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:16 UTC Ceribell, Inc. CBLL · Entity 4994 Exercise / conversionCommon Stock 2,500 $2.24 $5,600.00
Disclosure

SEC source: 0001193125-26-004760 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,076

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 18:02 UTC Ceribell, Inc. CBLL · Entity 4994 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0001193125-25-313867 · ownership.xml · derivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,150

Underlying: Common Stock · 5,000 shares

Expires 2029-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · derivative.exercise_date: The stock option is fully vested and currently exercisable.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 18:02 UTC Ceribell, Inc. CBLL · Entity 4994 SaleCommon Stock 5,000 $20.00 $100,000.00
Disclosure

SEC source: 0001193125-25-313867 · ownership.xml · nonDerivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,388

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 18:02 UTC Ceribell, Inc. CBLL · Entity 4994 Exercise / conversionCommon Stock 5,000 $2.24 $11,200.00
Disclosure

SEC source: 0001193125-25-313867 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,388

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 19:16 UTC Ceribell, Inc. CBLL · Entity 4994 SaleCommon Stock 827 $16.67 $13,786.09
Disclosure

SEC source: 0001193125-25-307906 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,388

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 03, 2025 Filed Sep 5, 2025 18:33 UTC Ceribell, Inc. CBLL · Entity 4994 SaleCommon Stock 827 $11.36 $9,394.72
Disclosure

SEC source: 0000950170-25-113220 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,215

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 16:31 UTC Ceribell, Inc. CBLL · Entity 4994 SaleCommon Stock 11,188 $17.85 $199,705.80
Disclosure

SEC source: 0000950170-25-088294 · ownership.xml · nonDerivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,042

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.8 to $17.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.

Read SEC document
June 17, 2025 Filed Jun 20, 2025 16:31 UTC Ceribell, Inc. CBLL · Entity 4994 SaleCommon Stock 7,445 $17.63 $131,255.35
Disclosure

SEC source: 0000950170-25-088294 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,230

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.9, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.

Read SEC document
June 17, 2025 Filed Jan 6, 2026 22:15 UTC Amendment Ceribell, Inc. CBLL · Entity 4994 SaleCommon Stock 7,445 $17.63 $131,255.35
Disclosure

SEC source: 0001193125-26-004759 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,230

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.9, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.

Read SEC document
June 16, 2025 Filed Jun 17, 2025 23:52 UTC Ceribell, Inc. CBLL · Entity 4994 Exercise / conversionStock Option (Right to Buy) · Derivative 19,455 $0.00 Strike: $3.65 $0.00
Disclosure

SEC source: 0000950170-25-087603 · ownership.xml · derivative · entry 6

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,455 shares

Expires 2031-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option is fully vested and exercisable as of the transaction date.

Read SEC document
June 16, 2025 Filed Jun 17, 2025 23:52 UTC Ceribell, Inc. CBLL · Entity 4994 Exercise / conversionStock Option (Right to Buy) · Derivative 545 $0.00 Strike: $2.24 $0.00
Disclosure

SEC source: 0000950170-25-087603 · ownership.xml · derivative · entry 5

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,150

Underlying: Common Stock · 545 shares

Expires 2029-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option is fully vested and exercisable as of the transaction date.

Read SEC document
June 16, 2025 Filed Jun 17, 2025 23:52 UTC Ceribell, Inc. CBLL · Entity 4994 SaleCommon Stock 20,000 $17.14 $342,800.00
Disclosure

SEC source: 0000950170-25-087603 · ownership.xml · nonDerivative · entry 4

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,675

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17 to $17.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.

Read SEC document
June 16, 2025 Filed Jun 17, 2025 23:52 UTC Ceribell, Inc. CBLL · Entity 4994 Exercise / conversionCommon Stock 19,455 $3.65 $71,010.75
Disclosure

SEC source: 0000950170-25-087603 · ownership.xml · nonDerivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,675

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 16, 2025 Filed Jun 17, 2025 23:52 UTC Ceribell, Inc. CBLL · Entity 4994 Exercise / conversionCommon Stock 545 $2.24 $1,220.80
Disclosure

SEC source: 0000950170-25-087603 · ownership.xml · nonDerivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,220

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 10, 2025 Filed Jun 17, 2025 23:52 UTC Ceribell, Inc. CBLL · Entity 4994 GrantCommon Stock 8,828 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-087603 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,675

F1 · shares: Represents 8,828 restricted stock units.

Read SEC document
May 22, 2025 Filed May 23, 2025 20:03 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 4,387 $0.00 $0.00
Disclosure

SEC source: 0001438133-25-000106 · wk-form4_1748030605.xml · derivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,387 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
May 22, 2025 Filed May 23, 2025 20:03 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 4,387 $20.64 $90,547.68
Disclosure

SEC source: 0001438133-25-000106 · wk-form4_1748030605.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,783

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 21, 2025 Filed May 23, 2025 20:03 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 8,759 $0.00 $0.00
Disclosure

SEC source: 0001438133-25-000106 · wk-form4_1748030605.xml · derivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,759

Underlying: Common Stock · 8,759 shares

Expires not disclosed

F4 · security: Awarded on May 21, 2025 pursuant to the 2023 Plan.

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
October 11, 2024 Filed Oct 16, 2024 20:20 UTC Ceribell, Inc. CBLL · Entity 4994 GrantCommon Stock 6,618 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-115010 · ownership.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,847

F1 · shares: Represents 6,618 restricted stock units ("RSUs").

F2 · balance_after: Represents 19,847 RSUs.

Read SEC document
May 24, 2024 Filed May 24, 2024 23:21 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 4,434 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000121 · wk-form4_1716592892.xml · derivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Awarded on May 24, 2023 pursuant to the 2023 Plan.

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
May 24, 2024 Filed May 24, 2024 23:21 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 4,434 $51.73 $229,370.82
Disclosure

SEC source: 0001438133-24-000121 · wk-form4_1716592892.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,396

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2024 Filed May 24, 2024 23:21 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 4,387 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000121 · wk-form4_1716592892.xml · derivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,387

Underlying: Common Stock · 4,387 shares

Expires not disclosed

F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
May 25, 2023 Filed May 26, 2023 20:16 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 2,757 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000109 · wf-form4_168513213829237.xml · derivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,757 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

Read SEC document
May 25, 2023 Filed May 26, 2023 20:16 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 2,757 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000109 · wf-form4_168513213829237.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,962

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2023 Filed May 26, 2023 20:16 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRSU 2023 05 24 · Derivative 4,434 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000109 · wf-form4_168513213829237.xml · derivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,434

Underlying: Common Stock · 4,434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.

Read SEC document
May 25, 2022 Filed Jun 1, 2022 23:50 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRestricted Stock Unit · Derivative 2,757 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000141 · wf-form4_165412741951482.xml · derivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,757

Underlying: Common Stock · 2,757 shares

Expires not disclosed

F1 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

Read SEC document
May 18, 2022 Filed May 20, 2022 00:00 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 2,205 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000095 · wf-form4_165300479694005.xml · derivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,205 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company.

F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

Read SEC document
May 18, 2022 Filed May 20, 2022 00:00 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 2,205 $0.00 $0.00
Disclosure

SEC source: 0001438133-22-000095 · wf-form4_165300479694005.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,205

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 02, 2022 Filed May 4, 2022 21:04 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,500 $34.00 Strike: $34.00 $51,000.00
Disclosure

SEC source: 0001438133-22-000062 · wf-form4_165169807583447.xml · derivative · entry 4

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,892

Underlying: Common Stock · 1,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
May 02, 2022 Filed May 4, 2022 21:04 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 967 $97.10 $93,895.70
Disclosure

SEC source: 0001438133-22-000062 · wf-form4_165169807583447.xml · nonDerivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $96.77 to $97.37. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
May 02, 2022 Filed May 4, 2022 21:04 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 533 $96.05 $51,194.65
Disclosure

SEC source: 0001438133-22-000062 · wf-form4_165169807583447.xml · nonDerivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 967

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $95.60 to $96.51. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
May 02, 2022 Filed May 4, 2022 21:04 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,500 $34.00 $51,000.00
Disclosure

SEC source: 0001438133-22-000062 · wf-form4_165169807583447.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:28 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,500 $34.00 Strike: $34.00 $51,000.00
Disclosure

SEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · derivative · entry 5

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,392

Underlying: Common Stock · 1,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:28 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 533 $118.82 $63,331.06
Disclosure

SEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 4

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.

F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $118.52 to $119.50. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:28 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 667 $117.89 $78,632.63
Disclosure

SEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 533

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.46 to $118.29. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:28 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 300 $116.63 $34,989.00
Disclosure

SEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $116.33 to $116.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:28 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,500 $34.00 $51,000.00
Disclosure

SEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 20:53 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 1,108 $34.00 Strike: $34.00 $37,672.00
Disclosure

SEC source: 0001438133-21-000199 · wf-form4_163597280304758.xml · derivative · entry 4

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,892

Underlying: Common Stock · 1,108 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 20:53 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 278 $136.35 $37,905.30
Disclosure

SEC source: 0001438133-21-000199 · wf-form4_163597280304758.xml · nonDerivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $136.19 to $136.53. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 20:53 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 1,222 $135.64 $165,752.08
Disclosure

SEC source: 0001438133-21-000199 · wf-form4_163597280304758.xml · nonDerivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $135.05 to $136.04. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 20:53 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,108 $34.00 $37,672.00
Disclosure

SEC source: 0001438133-21-000199 · wf-form4_163597280304758.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
August 02, 2021 Filed Aug 3, 2021 22:36 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 SaleCommon Stock 1,500 $107.51 $161,263.95
Disclosure

SEC source: 0001438133-21-000114 · wf-form4_162803018374811.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 392

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $107.50 to $107.56. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
June 09, 2021 Filed Jun 10, 2021 20:59 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionStock Option · Derivative 500 $34.00 Strike: $34.00 $17,000.00
Disclosure

SEC source: 0001438133-21-000098 · wf-form4_162335875512522.xml · derivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019.

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.